FDA sets up panel to advise on genetic testing:
This article was originally published in Clinica
Executive Summary
The US FDA is setting up a new advisory committee on genetic testing. The new panel will provide advice on the appropriate scientific criteria to diagnostically test for human genes, make recommendations on product applications, review guidance and recommend criteria and classification of tests for human genes. Nominations to serve on the panel, which will have industry and consumer representation, should be received by October 27.